Management of anti-NMDAR encephalitis with Rituximab: Case report in a Public Hospital of Lima, Peru
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.153.1324Keywords:
Encephalitis, Antibodies, Antinuclear, Encefalitis Antirreceptor N-Metil-D-Aspartato, PeruAbstract
Introduction: Autoimmune encephalitis comprises a wide spectrum of immunological disorders, among them anti-NMDAR is the most frequent. The management of this pathology is complex due to multiple circumstances. Case report: A 19-year-old woman who started a subacute clinical picture with associated behavioral and neurological disorder: hallucinations, heteroaggressiveness, akinetic mutism, epileptic seizures, orofacial dyskinesias, fever and reported transient cardiac arrhythmia. MRI was normal, EEG recorded delta brush waves, CSF and serum studies were negative for secondary causes. Treatment was started with Acyclovir, an anti-crisis drug, and psychotropic drugs, later methylprednisolone with immunoglobulin was started without a satisfactory response. She starts treatment with Rituximab presenting a favorable response. The CSF panel was positive for NMDA. Control with progressive de-escalation of anti-crisis medications and psychotropic drugs is indicated. Conclusion: It is important to recognize early the clinical manifestations of this entity in order to carry out timely management that could improve the prognosis.
Downloads
Metrics
References
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016 Apr 1;15(4):391–404. Doi: 10.1016/S1474-4422(15)00401-9
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021 Jul 1;92(7):757–68. Doi: 10.1136/jnnp-2020-325300
Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Annals of Neurology. 2018;83(1):166–77. Doi: 10.1002/ana.25131
Gagnier JJ, Kienle G, Altman DG, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med 2013;2:38–43. doi:10.7453/gahmj.2013.008.
Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Current Opinion in Neurology. 2014 Jun;27(3):361–8. Doi: 10.1097/WCO.0000000000000087
Coronado-Sarmiento Juan, Mendoza Tatiana, Restrepo-Escobar Jorge. Encefalitis autoinmune. Rev Ecuat Neurol. 2021 Sep;30( 2 ): 94-97. Doi: https://doi.org/10.46997/revecuatneurol30200094
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. The Lancet Infectious Diseases. 2010 Dec 1;10(12):835–44. Doi: 10.1016/S1473-3099(10)70222-X
Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, et al. Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Developmental Medicine & Child Neurology. 2017;59(8):796–805.doi: 10.1111/dmcn.13448
Vences MA, Saquisela VV, Barreto-Acevedo E, Zuñiga MA. Anti-NMDAR Encephalitis: Case report with a long – term follow-up. Rev Neuropsiquiatr. 2020; 83(2):110-115. Doi: http://dx.doi.org/10.20453/rnp.v83i2.3753
Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. American Journal of Neuroradiology. 2017 Jun 1;38(6):1070–8. Doi: 10.3174/ajnr.A5086
Monaco S, Mariotto S, Bolzan A, Ferrari S, Alessandrini F. Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis. Neurol Sci. 2021 Apr 1;42(4):1567–9. Doi: 10.1007/s10072-020-04799-3
Rüegg S, Yeh EA, Honnorat J. Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers needed. Neurology. 2019 Jan 15;92(3):119–20. Doi: 10.1212/WNL.0000000000006766
Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):e244-e252. Doi: 10.1212/WNL.0000000000006783
Abbatemarco JR, Rodenbeck SJ, Day GS, Titulaer MJ, Yeshokumar AK, Clardy SL. Autoimmune Neurology: The Need for Comprehensive Care. Neurology - Neuroimmunology Neuroinflammation. 2021 Sep 1;8(5). Doi: 10.1212/NXI.0000000000001033
Neyens RR, Gaskill GE, Chalela JA. Critical Care Management of Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Crit Care Med. 2018 Sep;46(9):1514-1521. Doi: 10.1097/CCM.0000000000003268
Samanta D, Lui F. Anti-NMDA Receptor Encephalitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 25, 2021. Doi: https://pubmed.ncbi.nlm.nih.gov/31869136/
Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021 Aug 1;92(8):897–907. Doi: 10.1136/jnnp-2020-325302
Collao-Parra JP, Romero-Urra C, Delgado-Derio C. Encefalitis autoinmunes: criterios diagnósticos y pautas terapéuticas [Autoimmune encephalitis. A review]. Rev Med Chil. 2018 Mar;146(3):351-361. Doi: http://dx.doi.org/10.4067/s0034-98872018000300351
Torres-Ballesteros Viviana, Murcia-Rojas Diana, Ochoa-Urrea Manuela, Vargas-Osorio Juliana, Bernal-Pacheco Oscar, Moreno Moreno Josué. Las diferentes facetas de la encefalitis autoinmune. Acta Neurol Colomb. 2020 Mar; 36( 1 ): 39-46. Doi: https://doi.org/10.22379/24224022276
García-Beristáin JC, Barragán-Pérez E, Choperena-Rodríguez R, Reyes-Cruz G. Encefalitis autoinmune en pediatría Autoimmune encephalitis in pediatrics. Acta Pediatr Mex. 2017 jul;38(4):274-279. Doi: https://doi.org/10.18233/apm38no4pp274-2791436
Vasconcelos G de A, Barreira RM, Antoniollo KENT, Pinheiro AMN, Maia CFR, Alves DMBS, et al. Autoimmune Encephalitis in Latin America: A Critical Review. Frontiers in Neurology. 2021;11. Doi: 10.3389/fneur.2020.606350
Bruijn MAAM de, Sonderen A van, Coevorden-Hameete MH van, Bastiaansen AEM, Schreurs MWJ, Rouhl RPW, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology. 2019 May 7;92(19):e2185–96. Doi: 10.1212/WNL.0000000000007475
Palomino-Lescano H, Segura-Chávez D, Quispe-Orozco D, Castro-Suarez S, De la Cruz W, Zapata-Luyo W, et al. Encefalitis autoinmune mediada por anticuerpos contra el receptor N-Metil-N-Aspartato: reporte de cuatro casos en Perú. Rev Peru Med Exp Salud Publica. 2019;36(1):138-144. Doi: 10.17843/rpmesp.2019.361.3936
Caparó-Zamalloa C, Álvarez-Toledo K, Yamunaque-Chunga C, Castro-Suarez S, Guevara-Silva E, Osorio-Marcatinco V, et al. Autoimmune neurology: Co-occurrence of anti-NMDAR encephalitis and anti-MOG associated disease, report of a case. Journal of Neuroimmunology. 2021 Sep 15;358. Doi: 10.1016/j.jneuroim.2021.577663
Caycho-Gamarra Grecia A, Quispe-Rivas Mary C, Carreazo-Pariasca Nilton Yhuri, Muñoz-Huerta Pamela Rocío. Encefalitis anti-NMDAR: un caso pediátrico con afasia de expresión. Rev. mex. pediatr. 2019 Ago; 86(4): 151-154.doi: dx.doi.org/10.35366/SP194E
Vigil NR, Páucar JC, Coronel EB, Torres AC, Mendoza MC, Tomás MP, Vargas M P. A propósito de 3 casos de encefalitis con status epiléptico en el servicio de neurocirugía del Instituto Nacional de Ciencias Neurológicas. Revista de la Sociedad Peruana de Medicina Interna 29.4 (2016): 177-182. Doi: https://doi.org/10.36393/spmi.v29i4.100
Palomino-Lescano Henry Y, De la Cruz Walter, Segura-Chávez Darwin, Delgado-Río José C. Encefalitis por anticuerpos contra receptores de N-metil-D-aspartato y síndrome de DRESS secundario a fenitoína: Reporte de un caso. Rev Neuropsiquiatr. 2017 Jul; 80(3): 200-205. Doi: http://dx.doi.org/10.20453/rnp.v80i3.3157
Custodio N, Escobar-Montalvo J. Neurophychiatric symptoms in anti-N-methyl-D-aspartate receptor encephalitis: apropos of two cases. An. Fac. med. 2016 Jul; 77( 3 ): 277-281. Doi: / http://dx.doi.org/10.15381/anales.v77i3.12419
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Lucía B. Flores Lazo, Rubén Olivera Ruiz , Miguel A. Vences
This work is licensed under a Creative Commons Attribution 4.0 International License.
